Regeneron Pharmaceuticals (RGO.STU) Q2 2026 Earnings

29AprConfirmed
Q1 2026
Next
7.6
8.29
8.97
9.65

Details

Expected EPS
7.6024682901
Actual EPS
N/A
Surprise EPS
-7.6
Surprise Percent
+100%

Description

Regeneron Pharmaceuticals (RGO.STU) will report earnings of for Q2 2026 on April 29, 2026.

0 Comments

Share your thoughts